
Dhansa Labs Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Dhansa Labs Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.

Price Band
₹68
Per Share
Lot Size
2000 Shares

Minimum Investment
₹1,36,000

Issue Size
₹44.68 Cr

Face Value
₹10
Per Share
IPO Type
Book Building - SME

Retail Quota
35%

QIB Quota
50%

NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Dhansa Labs Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
94.97%
Promoter Holding (Post-Issue)
69.95%
Issue Type
Book Building - SME
ISIN
INE0M3I01029
About the Company
Ambey Laboratories Limited was founded by Mr. Anil Kumar Gupta along with Mr. Kewal Sehgal as a private limited company under the name and style of Ambey Laboratories Private Limited on 20th March,1985 registered under Companies Act, 1956 with a motive of carrying business activities in the chemical industry and a focus on crop protection to support the agricultural activities in the country. Besides this, Ambey carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides. Its operations are spread across India and abroad with manufacturing facility in Rajasthan- India, spanning for over 20183.50 SQM of land. The Company has continuously demonstrated strong growth throughout the years in a number of business areas and global expansions. Its ultimate goal is to further establish its standing as a dependable and trustworthy global and Indian partner. Presently the company manufactures 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP 2,4-D Amine 866, 720, 480g/l SL 2,4-D Ethyl Hexyl Ester 96% TC 2,4-D Ethyl Ester 96% TC Chlorpyriphos 97%TC / 20%EC / 50%EC Thiamethoxam 96%TC / 25%WG / 75%SG Pretilachlor 95%TC / 50%EC / 37%EW Metribuzin 97%TC / 70%WS Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC and Metalaxyl 98%TC / 35% WS for its customer base which comprises of large corporate.
Industry Overview
CHEMICALS SECTOR As per Chemexcil (Chemicals Export Promotion Council), India's agrochemical export was estimated to be at US$ 1.04 billion from April 2023-June 2023 (Provisional). Indian colorants industry has emerged as a key player with a global market share of ~15%. The country's chemicals industry is de-licensed, except for few hazardous chemicals. India has traditionally been a world leader in generics and biosimilars and a major Indian vaccine manufacturer, contributing more than 50% of the global vaccine supply. India holds a strong position in exports and imports of chemicals at a global level and ranks 14th in exports and 8th in imports at global level (excluding pharmaceuticals). From April 2023 to June 2023 (provisional), India's dye exports (Dyes and Dye Intermediates) totalled US$ 561.56 million. HERBICIDES: Farmers have faced weed-related issues and solutions from the beginning of agricultural history. Farmers' ability to lessen crop-weed competition expanded with the introduction of tractors and improvements in mechanization tools. However, the development of synthetic and related herbicides gave farmers, horticulturists, and foresters the ability to manage broad leaf weeds in broad leaf crops, narrow leaf weeds in narrow leaf crops, or broad leaf weeds in narrow leaf crops in addition to narrow leaf weeds in broad leaf crops. The earliest attempt to control weeds in India with herbicides was made in 1937 in Punjab for controlling Carthamus oxyacantha by using sodium arsenite. 2,4-D was first tested in India in 1946. Since then, a number of herbicides have been imported and tried for their effectiveness in controlling many weed species. The herbicide use, in comparison to industrialized countries, is significantly low in India till today. Albeit the crop loss is more due to the weed infestation than that caused by other pests. The Ministry of Agriculture, Government of India regulates the manufacture, sale, import, export and use of herbicides through the 'Insecticides Act, 1968'. Central Insecticides Board (CIB) constituted under Section 4 of the Act advises Central and State Governments on technical matters. The Registration Committee (RC) constituted under section 5 of the Act approves the use of pesticides and new formulations to tackle the pest problem in various crops. The Registration Committee is responsible to register pesticides after scrutinizing the chemistry, bio efficacy and toxicology of the products. Herbicides applied in combination either pre-plant incorporated or pre-emergence or postemergence generally increase the spectrum of weed control or the length of residual weed control. Tank-mixing of herbicides may improve the spectrum of weeds controlled in a single application which saves time and labour in a weed management programme. Mixing compatible herbicides from different chemical families may improve control of specific weed populations. Herbicide combinations may also provide control of several weed types at the same time, such as grassy and broadleaf weeds.
Company History
Ambey Laboratories Limited was originally incorporated as "Ambey Laboratories Private Limited" on March 20, 1985, as a Private Limited Company under the provisions of the Companies Act, 1956 bearing Corporate Identification Number U74899DL1985PTC020490 pursuant to Certificate of Incorporation issued by Registrar of Companies, Delhi. Subsequently, the Company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of the Company at the Extra Ordinary General Meeting held on November 15th 2014. and name of the Company was changed to "Ambey Laboratories Limited" and a fresh Certificate of Incorporation dated December 30, 2014, was issued by Registrar of Companies, Delhi. As on date of this Draft Prospectus, the Corporate Identification Number of the Company is U74899DL1985PLC020490.
Products & Services
- Ambey carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides.
Growth Strategy
- Continue improving financial performance through focus on operational and functional efficiencies.
- Backward integration for Manufacturing Raw material and forward integration of Finished Goods.
- Increase in Installed Capacity.
- Leveraging its market skills, relationship and leadership position in 2, 4 D.
- Increase wallet share with existing customers and continued focus to expand customer base.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY23 to FY25.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offering of up to 65,70,000 equity shares of Rs. 10/- each ("Equity Shares") of Ambey Laboratories Limited ("Ambey" or the "Company") for cash at a price of Rs. 68/- per equity share (the "Issue Price"), aggregating to Rs. 44.68 crores ("The Offer"), comprising a fresh issue of up to 62,58,000 equity shares aggregating to Rs. 42.55 crores by the company ("Fresh Issue") and an offer for sale of up to 3,12,000 equity shares by ("The Promoter Group Selling Shareholders" or "The Selling Shareholder") aggregating to Rs. 2.13 crores ("Offer for Sale"). Out of the offer, 3,30,000 equity shares aggregating to Rs. 2.24 crores will be reserved for subscription by market maker ("Market Maker Reservation Portion"). The offer less the market maker reservation portion i.e. offer of 62,40,000 equity shares of face value of Rs. 10.00/- each at an issue price of Rs. 68/- per equity share aggregating to Rs. 42.44 crores is hereinafter referred to as the "Net Offer". The offer and the net offer will constitute 26.34% and 25.01%, respectively of the post-issue paid-up equity share capital of the company. Price Band: Rs. 68 per equity share of face value of Rs. 10/- each. The issue price is 6.80 times of the face value at the lower price band and the upper price band respectively.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Experienced Management Team.
- Prime Location of its Manufacturing Facility
- Quality Assurance and Standards.
- Cordial Relationships with its Suppliers.
- A few of its properties including Registered Office of the Company, are not owned by it. In the event, the company is unable to renew the lease/ rent agreements, or if such agreements are terminated, its may suffer a disruption in the company operations.
- Rajasthan State Pollution Control Board has directed the company to deposit the amount to the tune of Rs.1,92,02,400 towards environment compensation.
- Its Board of Directors and Management may change the company operating policies and strategies without prior notice or shareholders' approval.
- Some of the raw materials that the company use as well as its finished products are hazardous, corrosive and flammable and require expert handling and storage, as applicable. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.
- Its funding requirements and deployment of the issue proceeds are based on management estimates and have not been independently appraised by any bank or financial institution and actual cost may vary compared with the estimated amount.